BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 15, 2004
View Archived Issues
Increased survival found in multiple myeloma patients treated with erythropoietin
Read More
In vivo detection of antiangiogenic activity of SU-6668 by enhanced MRI technique
Read More
Greater benefits associated with intensive lipid-lowering therapy after acute coronary syndrome
Read More
Pulmonary hypertension and increased mortality in sickle cell disease
Read More
New antibody program in Centocor/MorphoSys collaboration
Read More
Phase II program under way for extended-release Sonata
Read More
Novavax comments on findings of estrogen-alone arm of WIH study
Read More
Preclinical neurochemical profile of sarizotan, a dual 5-HT1A agonist and D2 antagonist
Read More
Complete genome of S. erythracea sequenced
Read More
Patent notice of allowance for Zestra
Read More
Vical's CMV vaccine efforts supported by NIAID grants
Read More
Astex Technology and Boehringer Ingelheim enter drug discovery alliance
Read More
Compound Therapeutics confirms acquisition of Phylos
Read More
NOX-100 produces positive results in phase I/IIa septic shock study
Read More
New phase IIb trial evaluates alagebrium chloride for systolic hypertension
Read More
New tryptase inhibitors emerge from Altana R&D
Read More
New fatty acid-camptothecin conjugates developed at Panorama
Read More
Two series of antiangiogenic macrolides designed by Mercian and Eisai scientists
Read More
Aventis claims three series of eNOS upregulators
Read More
Kyoto Pharmaceutical presents new inhibitors of ACAT and lipid peroxidation
Read More
Novel RdRp inhibitors discovered by Micrologix researchers
Read More
Novel CCK1 antagonists and their use reported by Rotta
Read More
Paxene receives European approval for metastatic breast and ovarian cancers
Read More
New Panzem formulation studied in phase I trial
Read More
New Lotronex dosage available
Read More
Topical PMX-53 improves psoriasis lesion scores in pilot study
Read More
NMED-160 enters clinical testing
Read More
Positive results reported from phase Ib/IIa trial of Hemospan
Read More
Presentation of new Riquent data
Read More
Iquix receives FDA approval for bacterial corneal ulcer
Read More
Elan achieves key R&D milestones during 2003
Read More
Additive neuroprotection of creatinine and COX-2 inhibitors in ALS transgenic mouse model
Read More